Search filters

List of works by Peter Nash

2018 update of the APLAR recommendations for treatment of rheumatoid arthritis

scientific article published on 27 February 2019

2019 update: EULAR RA management recommendations, efficacy and safety systematic literature reviews

scientific article published on 07 February 2020

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis

scientific article

APLAR rheumatoid arthritis treatment recommendations.

scientific article published on September 2015

Advances in rheumatoid arthritis

scientific article published on March 2017

Alefacept plus methotrexate for psoriatic arthritis

scientific article published on 01 September 2006

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3

scientific article

Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmona

scientific article published on October 2011

Assessment of patients with psoriatic arthritis: a review of currently available measures

scientific article published in January 2004

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database.

scientific article

Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison

scientific article published on 30 October 2018

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison

scientific article published on 01 July 2018

Consensus on a core set of domains for psoriatic arthritis

scientific article published in May 2007

Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

scientific article published in December 2018

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease ⬇️

scientific article published on 29 October 2018

Drug use and toxicity in psoriatic disease: focus on methotrexate

scientific article published in July 2008

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

scientific article published on 6 March 2017

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).

scientific article published on 17 January 2018

Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group

scientific article published on December 2009

Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health

scientific article published in July 2010

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

scientific article published on 16 October 2015

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

scientific article published on May 2004

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3).

scientific article published on 15 March 2018

Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs

scientific article published on 14 August 2015

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update ⬇️

scientific article published on 19 May 2015

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

scientific article published on 13 October 2012

GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. ⬇️

scientific article published on 28 November 2017

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

article

Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-b

scientific article published on 01 August 2009

Golimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function fin

scientific article

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

scientific article

How Can We Improve the Use of Established Therapies in PsA?

scientific article published on 01 August 2020

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial.

scientific article published on 28 July 2017

Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel‐Arm, Open‐Label Study ⬇️

scientific article published on May 1, 2013

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study

scientific article published on 01 July 2020

Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis

scientific article published on 5 August 2015

Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor in

scientific article published on 07 September 2018

Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.

scientific article

Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment

scientific article

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

scientific article

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

scientific article published on 01 October 2020

Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial.

scientific article published on 15 April 2018

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.

scientific article published on 17 January 2013

Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis

scientific article published on 26 February 2019

Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).

scientific article published on October 2009

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52

scientific article published on 13 July 2020

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study

scientific article

Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis

scientific article published on 18 August 2006

Outcome measures in psoriatic arthritis

scientific article published on 1 May 2007

Outcome measures in psoriatic arthritis

scientific article published on 1 November 2005

Patient and Healthcare Professionals Preference for Brenzys vs. Enbrel Autoinjector for Rheumatoid Arthritis: A Randomized Crossover Simulated-Use Study.

scientific article

Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.

scientific article published in November 2013

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

scientific article published on 06 November 2020

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research

scientific article published on 01 November 2020

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

scientific article

Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.

scientific article published on May 2003

Psoriatic arthritis therapy: NSAIDs and traditional DMARDs.

scientific article published on March 2005

Psoriatic arthritis: novel targets add to a therapeutic renaissance

scientific article published on 01 June 2018

Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis.

scientific article published on June 2009

Real-world Evidence Needs Careful Interpretation

scientific article published on 01 January 2021

Registries in systemic sclerosis: a worldwide experience ⬇️

scientific article published on January 1, 2011

Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: A cross-sectional, multicenter study.

scientific article published in July 2010

Remission in psoriatic arthritis-where are we now? ⬇️

scientific article published on 16 October 2017

Reply

scientific article published on 01 July 2016

Rheumatoid arthritis in the Middle East and Africa: are we any closer to optimising its management?

scientific article published on 7 November 2014

Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2

scientific article published on 01 November 2018

Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials

scientific article published on 12 February 2019

Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.

scientific article

Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis

scientific article published on 19 September 2018

Short course prednisolone for adhesive capsulitis (frozen shoulder or stiff painful shoulder): a randomised, double blind, placebo controlled trial

scientific article published on November 2004

Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial.

scientific article

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.

scientific article published on October 2011

Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed

scientific article published on 20 June 2011

The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy

scientific article published on 01 September 2009

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

scientific article published on 13 July 2012

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

scientific article published on January 2013

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study

scientific article published on 24 April 2019

Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population

scientific article published on 11 June 2018

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force ⬇️

scientific article published on 12 May 2015

Treatment goals for moderate to severe psoriasis: an Australian consensus.

scientific article published on 18 January 2013

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib

scientific article published on 23 February 2019

Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitors.

scientific article published on 18 April 2018

Treatment recommendations for psoriatic arthritis.

scientific article published on 24 October 2008

Updated guidelines for the management of axial disease in psoriatic arthritis

scientific article

Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group

scientific article published on 14 May 2010

Vertebral Fracture Risk With Long-term Corticosteroid Therapy

article

Paulina is supported by:

About Paulina

Help